Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3
about
Propranolol blocks cardiac and neuronal voltage-gated sodium channelsMutation location effect on severity of phenotype during exercise testing in type 1 long-QT syndrome: impact of transmembrane and C-loop location.A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers.Cardiac sodium channelopathies.Location, location, regulation: a novel role for β-spectrin in the heart.Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprololPharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs.Recent progress in congenital long QT syndromeThe Effects of Isoproterenol and Propranolol on Cytokine Profile Secretion by Cultured Tumor-infiltrating Lymphocytes Derived from Colorectal Cancer PatientsMolecular Pathophysiology of Congenital Long QT Syndrome.Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome.In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia.Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis.β-blockers in congenital short-QT syndrome as ion channel blockers.The congenital long QT syndrome Type 3: An update.
P2860
Q21129289-9F1326BB-02DB-426F-954D-906F05D979BAQ33162791-FD7D4583-0267-45D2-938E-F83BEA8BACBAQ33164518-E75959BC-940F-4DEA-9B3B-44BA1F21AB28Q33906972-FC53E669-ED02-4BA3-BCD5-B8C48C84E6B1Q34162722-F02C965E-D752-4C45-AC31-7B51A9B1764EQ34307224-68E3A498-FCA4-42AB-881E-5A6685776EB9Q34482842-E0E9E105-55D1-42CE-99A2-381F8B2911BDQ35150971-F12E9F75-4285-40EF-A020-A4503143A910Q36645239-979230B3-6631-4EBC-B022-8204FFE16A26Q38997049-E4A19661-92C8-4A00-8E0F-531F6384A86AQ39452111-357E9BBD-F017-417E-B642-45C534E9A2E3Q42742246-19CE3C30-9DFE-4927-AB9E-82FF808DB8A1Q43179403-6A18622A-C333-476C-8F5F-393E7110090EQ47926450-3611DBEE-901B-4453-9028-2D586B7864A8Q50176761-C1F5864B-AA4D-487D-AA2A-95D5BD72DB3B
P2860
Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Molecular determinants of loca ...... of long QT syndrome variant 3
@en
Molecular determinants of loca ...... of long QT syndrome variant 3.
@nl
type
label
Molecular determinants of loca ...... of long QT syndrome variant 3
@en
Molecular determinants of loca ...... of long QT syndrome variant 3.
@nl
prefLabel
Molecular determinants of loca ...... of long QT syndrome variant 3
@en
Molecular determinants of loca ...... of long QT syndrome variant 3.
@nl
P2860
P1476
Molecular determinants of loca ...... of long QT syndrome variant 3
@en
P2093
John R Bankston
Robert S Kass
P2860
P304
P356
10.1016/J.YJMCC.2009.05.012
P577
2009-05-28T00:00:00Z